Neil Pothier, Ph.D.

Pharmacovigilance in Australia and New Zealand

Monday, March 01, 2010

Drug Supply Modelling in Clinical Trials (Statistical Methodology)

Sunday, May 01, 2011

Criteria for CMO Selection

Tuesday, September 01, 2009

Off-shoring Stability Testing Conducting Cost-efficient Compliant Long-term Stability Studies at Overseas CRO’s

Wednesday, September 01, 2010

Biopharmaceutical Contract Manufacturing Market: Outsourcing – What Services are Biomanufacturing Directors Looking for from CMOs?

Wednesday, September 01, 2010

Outsourcing Compound Inventory Trend or Real Benefits?

Monday, November 01, 2010

Plastic Pre-fillable Syringes and Vials: Progress Towards a Wider Acceptance

Friday, January 01, 2010

Process Validation Challenges for Technology Transfer

Friday, July 01, 2011

Practical Approaches in Applying Process Analytical Technology (PAT) Tools to Early Active Pharmaceutical Ingredient (API) Development

Friday, July 01, 2011

Is It Worth the Risk without Temperature Monitoring?

Saturday, January 01, 2011

The Integrated Local CMC Service Provider: Toward a Deep Economy of Pharmaceuticals

Friday, January 01, 2010

Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)

Tuesday, March 01, 2011

AN INTERVIEW WITH...Charles River Endotoxin and Microbial Detection

Monday, March 01, 2010

A Regulatory Approach to Contract Manufacturing

Monday, March 01, 2010

Conducting Release and Stability Studies for Blinded Comparators

Wednesday, September 01, 2010

Where Do Consultants Fit in to the Early Development API Supply Chain?

Thursday, July 01, 2010

Managing Vendor Relationships

Friday, January 01, 2010

Evolutionary Thinking: Pfizer Continues to Set a New Pace for Drug Development

Wednesday, September 01, 2010

In-house Contract Research and Manufacturing

Saturday, January 01, 2011

Changes That May Be Affecting API

Sunday, November 01, 2009

Neil Pothier, Ph.D.

Articles by Neil Pothier, Ph.D.

Pharmacovigilance in Australia and New Zealand

Drug Supply Modelling in Clinical Trials (Statistical Methodology)

Criteria for CMO Selection

Off-shoring Stability Testing Conducting Cost-efficient Compliant Long-term Stability Studies at Overseas CRO’s

Biopharmaceutical Contract Manufacturing Market: Outsourcing – What Services are Biomanufacturing Directors Looking for from CMOs?

Outsourcing Compound Inventory Trend or Real Benefits?

Plastic Pre-fillable Syringes and Vials: Progress Towards a Wider Acceptance

Process Validation Challenges for Technology Transfer

Practical Approaches in Applying Process Analytical Technology (PAT) Tools to Early Active Pharmaceutical Ingredient (API) Development

Is It Worth the Risk without Temperature Monitoring?

The Integrated Local CMC Service Provider: Toward a Deep Economy of Pharmaceuticals

Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)

AN INTERVIEW WITH...Charles River Endotoxin and Microbial Detection

A Regulatory Approach to Contract Manufacturing

Conducting Release and Stability Studies for Blinded Comparators

Where Do Consultants Fit in to the Early Development API Supply Chain?

Managing Vendor Relationships

Evolutionary Thinking: Pfizer Continues to Set a New Pace for Drug Development

In-house Contract Research and Manufacturing

Changes That May Be Affecting API

2024 Contract Services Directory and Guide

2024 Contract Services Directory and Guide

Subscriptions

Connect with Us

Sign up for our eNewsletter!